Catheter Precision, Inc. (VTAK)

Every figure this model derived for VTAK, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 21,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 1,839,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 2,510,000 AssetsCurrent 2026-06-30
current liabilities 13,452,000 LiabilitiesCurrent 2026-06-30
equity 17,561,000 StockholdersEquity 2026-06-30
interest expense 35,000 InterestPaidNet 2026-06-30
ocf -9,352,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 1,915,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 479,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up VTAK on one particular measure came for.

RatioValue
cash operating margin-876.76
current ratio0.19
current ratio reported0.19
dilution pct529.89
fcf margin-489.45
growth cv2.03
interest cover-547.29
operating margin-1000.26
owner earnings margin-514.46
revenue growth219.17
revenue growth per share-49.33
roic-80.49
rule of 40-781.09
sbc pct revenue25.01

What to be careful about

What this model itself distrusts about VTAK's figures. Written by the derivation as it ran, not added afterwards.